Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
25
# OF OVERLAPPING
HOLDINGS
HELX
67
HOLDINGS
45%
ALSO IN WDNA
WDNA
85
HOLDINGS
32%
ALSO IN HELX
SECTOR DRIFT (HELX minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HELX |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 6.9% | 2.9% | 2.9% |
|
ELI LILLY & CO | 2.7% | 3.1% | 2.7% |
|
UNITED THERAPEUTICS CORP | 3.4% | 2.3% | 2.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 2.8% | 2.1% | 2.1% |
|
IONIS PHARMACEUTICALS, INC. | 2.0% | 2.2% | 2.0% |
HELX Overweight Relative to WDNA
|
GUARDANT HEALTH, INC. | 6.8% |
|
MEDPACE HOLDINGS, INC. | 4.4% |
|
INSMED INC | 4.3% |
|
NATERA INC | 4.0% |
|
BRIDGEBIO PHARMA, INC. | 3.3% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 3.1% |
|
KRYSTAL BIOTECH, INC. | 3.1% |
|
LIGAND PHARMACEUTICALS-CL B | 3.0% |
|
GENEDX HOLDINGS CORP. CLASS A | 2.3% |
HELX Underweight Relative to WDNA
|
JOHNSON & JOHNSON | -2.7% |
|
MODERNA, INC. | -2.6% |
|
PFIZER INC | -2.4% |
|
REGENXBIO, INC. | -2.3% |
|
AMGEN INC | -2.2% |
|
AMICUS THERAPEUTICS INC | -2.2% |
 |
NOVO NORDISK A/S-B | -2.2% |
|
NOVOZYMES A/S-B SHARES | -2.0% |
|
IMMUNOME, INC. | -1.9% |
|
GILEAD SCIENCES INC | -1.7% |